Cephalon Provigil Focus: Studying ADHD In Children, Filing Shift Work sNDA

Cephalon plans to meet with FDA to discuss clinical requirements for a Provigil attention deficit hyperactivity disorder indication following positive results from a Phase II pediatric study, CEO Frank Baldino, PhD, said